Cargando…
Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis
BACKGROUND: Gastric cancer is the third leading cause of cancer-related death worldwide, for which several novel therapeutic strategies have been developed. Cisplatin (CDDP) mainly exerts its anti-gastric cancer effects; however, drug resistance limits its use. Thus, the development of drugs that ca...
Autores principales: | Liu, Chengwei, Li, Dongchang, Wang, Jian, Wang, Zhengguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618551/ https://www.ncbi.nlm.nih.gov/pubmed/37920505 http://dx.doi.org/10.1016/j.heliyon.2023.e21110 |
Ejemplares similares
-
Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression
por: Chen, Ke, et al.
Publicado: (2022) -
Mechanisms of alkaliptosis
por: Chen, Fangquan, et al.
Publicado: (2023) -
ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells
por: Que, Dongwen, et al.
Publicado: (2023) -
Arenobufagin intercalates with DNA leading to G(2) cell cycle arrest via ATM/ATR pathway
por: Deng, Li-Juan, et al.
Publicado: (2015) -
Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy
por: Jiaying, Yang, et al.
Publicado: (2023)